Acid-suppression therapy offers varied laryngopharyngeal and esophageal symptom relief in laryngopharyngeal reflux patients

Digestive Diseases and Sciences

Volumn 53, Issue 8, 2008, Pages 2033-2038

  Oridate, Nobuhiko ^a   Takeda, Hiroshi ^a   Asaka, Masahiro ^a   Nishizawa, Noriko ^a   Mesuda, Yasushi ^a   Mori, Mika ^a   Furuta, Yasushi ^a   Fukuda, Satoshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acid suppression therapy; Gastresophageal reflux disease; Laryngopharyngeal reflux; Symptom relief

Indexed keywords

BACTERIUM ANTIBODY; LANSOPRAZOLE; RABEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROENDOCRINE CELL; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; LARYNGOPHARYNGEAL REFLUX; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTIBODIES, BACTERIAL; DRUG ADMINISTRATION SCHEDULE; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMANS; LARYNGEAL DISEASES; MALE; MIDDLE AGED; PHARYNGEAL DISEASES; PROTON PUMP INHIBITORS; TREATMENT OUTCOME;

EID: 46449083292     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0114-9     Document Type: Article

References (18)

1. Koufman JA (1991) The otolaryngologic manifestations of gastro-esophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101:1-78
2. Hopkins C, Yousaf U, Pedersen M (2005) Acid reflux treatment for hoarseness (protocol). Cochrane Database Syst Rev 3. Accession no. 00075320-10000000-03935
3. Ford CN (2005) Evaluation and management of laryngopharyngeal reflux. J Am Med Assoc 294:1534-1540
4. Book DT, Rhee JS, Toohill RJ, Smith TL (2002) Perspectives in laryngopharyngeal reflux: an international survey. Laryngoscope 112:1399-1406
5. Berardi RR (2000) A critical evaluation of proton pump inhibitors in the treatment of gastresophageal reflux disease. Am J Manag Care 6:S491-S505
6. Vaezi MF (2003) Extraesophageal manifestations of gastresophageal reflux disease. Clin Cornerstone 5:32-38
7. Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, Vaezi MF (2005) Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 115:1230-1238
8. Oridate N, Takeda H, Yamamoto J, Asaka M, Mesuda Y, Nishizawa N, Mori M, Furuta Y, Fukuda S (2006) Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms. Laryngoscope 116:547-553
9. Belafsky PC, Postma GN, Koufman JA (2002) Validity and reliability of the Reflux Symptom Index (RSI). J Voice 16:274-277
10. Belafsky PC, Postma GN, Koufman JA (2001) The validity and reliability of the Reflux Finding Score (RFS). Laryngoscope 111:1313-1317
11. Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111:85-92
12. Kahrilas PJ (1996) Gastresophageal reflux disease. J Am Med Assoc 276:983-988
13. Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL (2004) The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope 114:670-674
14. Williams RB, Szczesniak MM, Maclean JC, Brake HM, Cole IE, Cook IJ (2004) Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. Am J Gastroenterol 99:777-785
15. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I (1995) Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 30:1046-1052
16. van Pinxteren B, Numans ME, Bonis PA, Lau J (2004) Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-esophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 4:CD002095
17. Raghunath A, Hungin AP, Wooff D, Childs S (2003) Prevalence of Helicobacter pylori in patients with gastro-esophageal reflux disease: systematic review. Brit Med J 326:737
18. Koike T, Ohara S, Sekine H, Iijima K, Kato K, Shimosegawa T, Toyota T (1999) Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 94:3468-3472